ANTIPSYCHOTICS
Psychiatric Uses Of Antipsychotic Drugs
1. Schizophrenia: Acute and Chronic Maintenance
2. Psychotic Depression (With Antidepressants)
3. Acute Mania (With Lithium)
4. Autism (For Control of Aggressive Behaviors)
5. Gilles de la Tourette’s Syndrome – Chronic Tics
6. Severe Agitation In Mentally Retarded
7.Alzheimer’s Patients
Pharmacological Actions of Antipsychotics At CNS Receptors
• Dopamine: Antagonists at D2 or Partial Agonist at D2 (aripiprazole)
• Serotonin: Antagonists at 5-HT2 A
• Histamine: Antagonists at H1
• Cholinergic: Antagonists at muscarinic M1-4
• Noradrenergic: Antagonists at α 1
Typical Antipsychotics Have Antagonist Actions That Are Greater for the Dopamine D2 Than the 5-HT2A Receptor
Phenothiazines & Derivatives
Chlorpromazine Fluphenazine
Perphenazine
Butyrophenones
Haloperidol
Atypical Antipsychotics Have Antagonist Actions that are Greater for 5-HT2A than D2
Risperidone
Olanzapine
Quetiapine
Clozapine
Ziprasidone
Dopamine Hypothesis Of Schizophrenia :An Increase in Dopaminergic Activity in CNS
1. All Antipsychotics are DA Receptor Antagonists
2. Therapeutic effects correlated with D2 affinity
3. Dopamine Agonists (e.g., Amphetamines) Exacerbate Schizophrenic Symptoms at Low Doses
4. Higher Doses of Amphetamines Induce Paranoid Psychotic Reactions in Normal Individuals
5. Evidence of Changes in Dopamine Receptors in Schizophrenia is Still Controversial
Blockade of Dopamine D2 Receptors
• Emotion - Reduces expression of emotion
• Cognitive functions – Decreases cognitive processes in prefrontal cortex
• Motor functions – Produces akinesia and symptoms of Parkinsonism
• Endocrine function – Produces increased release of prolactin
Psychiatric Uses Of Antipsychotic Drugs
1. Schizophrenia: Acute and Chronic Maintenance
2. Psychotic Depression (With Antidepressants)
3. Acute Mania (With Lithium)
4. Autism (For Control of Aggressive Behaviors)
5. Gilles de la Tourette’s Syndrome – Chronic Tics
6. Severe Agitation In Mentally Retarded
7.Alzheimer’s Patients
Pharmacological Actions of Antipsychotics At CNS Receptors
• Dopamine: Antagonists at D2 or Partial Agonist at D2 (aripiprazole)
• Serotonin: Antagonists at 5-HT2 A
• Histamine: Antagonists at H1
• Cholinergic: Antagonists at muscarinic M1-4
• Noradrenergic: Antagonists at α 1
Typical Antipsychotics Have Antagonist Actions That Are Greater for the Dopamine D2 Than the 5-HT2A Receptor
Phenothiazines & Derivatives
Chlorpromazine Fluphenazine
Perphenazine
Butyrophenones
Haloperidol
Atypical Antipsychotics Have Antagonist Actions that are Greater for 5-HT2A than D2
Risperidone
Olanzapine
Quetiapine
Clozapine
Ziprasidone
Dopamine Hypothesis Of Schizophrenia :An Increase in Dopaminergic Activity in CNS
1. All Antipsychotics are DA Receptor Antagonists
2. Therapeutic effects correlated with D2 affinity
3. Dopamine Agonists (e.g., Amphetamines) Exacerbate Schizophrenic Symptoms at Low Doses
4. Higher Doses of Amphetamines Induce Paranoid Psychotic Reactions in Normal Individuals
5. Evidence of Changes in Dopamine Receptors in Schizophrenia is Still Controversial
Blockade of Dopamine D2 Receptors
• Emotion - Reduces expression of emotion
• Cognitive functions – Decreases cognitive processes in prefrontal cortex
• Motor functions – Produces akinesia and symptoms of Parkinsonism
• Endocrine function – Produces increased release of prolactin
No comments:
Post a Comment